Beta 1 integrin predicts survival in breast cancer: a clinicopathological and immunohistochemical study

Beta 1 integrin predicts survival in breast cancer: a clinicopathological and immunohistochemical study

<p>Abstract</p> <p>Background</p> <p>The main focus of several studies concerned with cancer progression and metastasis is to analyze the mechanisms that allow cancer cells to interact and quickly adapt with their environment. Integrins, a family of transmembrane glycop...

Full description

Bibliographic Details
Main Authors:	dos Santos Petra, Zanetti Juliana S, Ribeiro-Silva Alfredo, Beltrão Eduardo IC
Format:	Article
Language:	English
Published:	BMC 2012-08-01
Series:	Diagnostic Pathology
Subjects:	β1 integrin Tissue microarray Immunohistochemistry Prognosis
Online Access:	http://www.diagnosticpathology.org/content/7/1/104

Similar Items

Clinicopathological and Prognostic Significance of a Panel of Tumor Biomarkers  in Lung Adenocarcinoma: a Tissue Microarray Study
by: Xin YANG, et al.
Published: (2014-03-01)

Immunohistochemical investigation of prognostic biomarkers in resected colorectal liver metastases: a systematic review and meta-analysis
by: William Torén, et al.
Published: (2018-12-01)

Combined use of immunohistochemical markers of basal and luminal subtypes in urothelial carcinoma of the bladder: Association with clinicopathological features and outcomes
by: Juliana Naves Ravanini, et al.
Published: (2021-04-01)

DSG2 expression is low in colon cancer and correlates with poor survival
by: Tingting Yang, et al.
Published: (2021-01-01)

Protein expression profiles and clinicopathologic characteristics associate with gastric cancer survival
by: Wei Li, et al.
Published: (2019-08-01)

Analysis of the expression and prognostic value of MT1-MMP, β1-integrin and YAP1 in glioma
by: Zhai Yangyang, et al.
Published: (2022-03-01)

High N-Cadherin Protein Expression in Ovarian Cancer Predicts Poor Survival and Triggers Cell Invasion
by: Mourad Assidi, et al.
Published: (2022-04-01)

Diagnostic Role and Prognostic Impact of PSAP Immunohistochemistry: A Tissue Microarray Study on 31,358 Cancer Tissues
by: Laura Sophie Tribian, et al.
Published: (2023-10-01)

High Density of CD16+ Tumor-Infiltrating Immune Cells in Recurrent Ovarian Cancer Is Associated with Enhanced Responsiveness to Chemotherapy and Prolonged Overall Survival
by: Alexandros Lalos, et al.
Published: (2021-11-01)

The Activation and Regulation of β2 Integrins in Phagocytes and Phagocytosis
by: Hao Sun, et al.
Published: (2021-03-01)

Microvessel Density and Clinicopathologic Characteristics in Hepatocellular Carcinoma With and Without Cirrhosis
by: Ivan Chebib, et al.
Published: (2007-01-01)

Correlation between Beta1 integrin expression and prognosis in clinically localized prostate cancer
by: Jose Pontes-Junior, et al.
Published: (2013-06-01)

High expression of SHP2 predicts a promising prognosis in colorectal cancer
by: Xibo Liu, et al.
Published: (2024-01-01)

Leptin Protein Expression and Promoter Methylation in Ovarian Cancer: A Strong Prognostic Value with Theranostic Promises
by: Mourad Assidi, et al.
Published: (2021-11-01)

High BCAR1 expression is associated with early PSA recurrence in ERG negative prostate cancer
by: Asmus Heumann, et al.
Published: (2018-01-01)

Pattern of placental alkaline phosphatase (PLAP) expression in human tumors: a tissue microarray study on 12,381 tumors
by: Viktor Reiswich, et al.
Published: (2021-11-01)

Immunohistochemical detection of virus through its nuclear cytopathic effect in idiopathic interstitial pneumonia other than acute exacerbation
by: G.C. dos Santos, et al.
Published: (2013-11-01)

The structural basis of β2 integrin intra-cellular multi-protein complexes
by: Bhattacharjya, Surajit
Published: (2022)

SMARCA2 deficiency in NSCLC: a clinicopathologic and immunohistochemical analysis of a large series from a single institution
by: Shanshan Sun, et al.
Published: (2022-02-01)

Integrin Alpha v Beta 6 (αvβ6) and Its Implications in Cancer Treatment
by: Ewa Brzozowska, et al.
Published: (2022-10-01)

Prognostic value of integrin αV expression and localization pattern in invasive breast carcinomas
by: Otto Luiz Dutra Cerqueira, et al.
Published: (2022-08-01)

The Terry Fox Research Institute Canadian Prostate Cancer Biomarker Network: an analysis of a pan-Canadian multi-center cohort for biomarker validation
by: Véronique Ouellet, et al.
Published: (2018-09-01)

Expressions and Significances of CRABPII and E-FABP  in Non-small Cell Lung Cancer
by: Qian LIU, et al.
Published: (2013-01-01)

Co-Expression of Immunohistochemical Markers MRP2, CXCR4, and PD-L1 in Gallbladder Tumors Is Associated with Prolonged Patient Survival
by: Andrés Tittarelli, et al.
Published: (2023-06-01)

Integrins β1 and β3 are biomarkers of uterine condition for embryo transfer
by: Guowu Chen, et al.
Published: (2016-10-01)

Relation of Nuclear Morphometry with Clinicopathologic Prognostic Parameters and Immunohistochemical ER, PR and Cerb-B2 Expressions in Breast Carcinoma
by: Murat ÇELİK, et al.
Published: (2021-08-01)

Perianal Paget’s disease: a clinicopathological and immunohistochemical study of 13 cases
by: Xiaoyan Liao, et al.
Published: (2020-03-01)

Comparative Studies of Vertebrate Beta Integrin Genes and Proteins: Ancient Genes in Vertebrate Evolution
by: Ujjwal K. Rout, et al.
Published: (2011-08-01)

Production of IL1-beta by ovarian cancer cells induces mesothelial cell beta1-integrin expression facilitating peritoneal dissemination
by: Watanabe Takafumi, et al.
Published: (2012-02-01)

Clinicopathological Significance and Prognostic Implications of REG4 Immunohistochemical Expression in Colorectal Cancer
by: Guhyun Kang, et al.
Published: (2021-09-01)

IMMUNOHISTOCHEMICAL ANALYSIS BY KI67 AND IDH1 IN PATIENTS WITH CHONDROSARCOMA
by: MARCELO BARBOSA RIBEIRO, et al.
Published: (2023-07-01)

The association and clinicopathological significance of Integrin alphavbeta6 and Rac1 expression in gastric carcinoma
by: Junjian Yu, et al.
Published: (2024-01-01)

Prognostic Significance of Cytoplasmic SPNS2 Expression in Patients with Oral Squamous Cell Carcinoma
by: Jeng-Wei Lu, et al.
Published: (2021-02-01)

Expression of P504s and claudin-4 in prostate cancer and prognostic value of their combined detection
by: BI Gang, et al.
Published: (2019-11-01)

Synthesis and Biological Evaluation of Cyclobutane-Based β3 Integrin Antagonists: A Novel Approach to Targeting Integrins for Cancer Therapy
by: Mark Sutherland, et al.
Published: (2023-08-01)

Integrin Beta 3 Regulates Cellular Senescence by Activating the TGF-β Pathway
by: Valentina Rapisarda, et al.
Published: (2017-03-01)

Evaluation of Beta-2 Integrin and Platelets Roles in Sickle Cell Disease Pathogenicity in Basrah Governorate Patients
by: Maha K. Al-Mishrey
Published: (2023-02-01)

Omics data-driven analysis identifies laminin-integrin-mediated signaling pathway as a determinant for cell differentiation in oral squamous cell carcinoma
by: Spoorti Kulkarni, et al.
Published: (2019-01-01)

Clinical significance of integrin αV and β superfamily members and focal adhesion kinase activity in oral squamous cell carcinoma: a retrospective observational study
by: Shigeru Sakurai, et al.
Published: (2024-01-01)

Prostein expression in human tumors: a tissue microarray study on 19,202 tumors from 152 different Tumor entities
by: Florian Viehweger, et al.
Published: (2024-01-01)